After binding of complement and antibody on the surface of encapsulated bacteria, the process of phagocytosis by polymorphonuclear leukocytes/macrophages is enhanced by all of the following opsonins, except?
**Core Concept**
The process of phagocytosis is enhanced by opsonins, which are molecules that mark the surface of pathogens, making them more recognizable and susceptible to ingestion by phagocytic cells such as polymorphonuclear leukocytes and macrophages. Opsonins can be antibodies, complement fragments, or other proteins that facilitate the binding of pathogens to phagocytes.
**Why the Correct Answer is Right**
Opsonization is a critical step in the innate immune response, as it enables phagocytes to identify and engulf pathogens more efficiently. The binding of complement and antibody to the surface of encapsulated bacteria creates a complex that is highly recognizable by phagocytic receptors, such as Fc receptors and complement receptors. This recognition leads to the activation of phagocytic pathways, resulting in the enhanced uptake and destruction of the pathogen.
**Why Each Wrong Option is Incorrect**
**Option A:** IgA is an antibody that plays a key role in mucosal immunity but is not typically involved in opsonization of encapsulated bacteria. While IgA can bind to pathogens, it does not activate the same phagocytic pathways as IgG or complement.
**Option B:** C3b is a fragment of the complement component C3 that is a potent opsonin. It binds to the surface of pathogens and enhances phagocytosis by activating complement receptor 1 (CR1) on phagocytes.
**Option C:** Fibrinogen is a protein that plays a key role in blood clotting but is not typically involved in opsonization. While fibrinogen can bind to pathogens, it does not activate the same phagocytic pathways as IgG or complement.
**Option D:** Mannose-binding lectin (MBL) is a protein that binds to carbohydrate moieties on the surface of pathogens and activates the lectin pathway of complement. It is a potent opsonin that enhances phagocytosis.
**Clinical Pearl / High-Yield Fact**
In clinical settings, the presence of opsonins on the surface of pathogens can be enhanced by the administration of immune serum globulin (ISG), which contains antibodies against a wide range of pathogens.
**Correct Answer:** A.